SEMPA is now accepting applications for its Committees and new ACEP State Chapter Liaison program. Learn more about SEMPA Committees and ACEP State Chapter Liaison program, requirements and to get the application.
The deadline to submit an application is February 23.
What could be better than the sun, surf and sights of San Diego? How about SEMPA 360 in sunny San Diego! When you register for SEMPA 360, you'll not only receive the most comprehensive and in-depth EMPA education, you'll get one-of-a-kind San Diego experiences.
Network with your colleagues aboard the USS Midway for the SEMPA 360 Opening Reception. Enjoy the beautiful marina when you participate in the first-ever SEMPA 360 5K Run/Walk. Explore the famous San Diego Zoo, get up-close with marine life at SeaWorld or enjoy a stroll on the magnificent beaches. Stay in the heart of the San Diego Marina - reserve your hotel in the SEMPA housing block at the Manchester Grand Hyatt.
Learn more and register today to join hundreds of your EMPA colleagues!
Are you looking for CME opportunities? National Stroke Association has the perfect FREE opportunity for you. Evidence-Based Medicine: An Update on Endovascular Stroke Treatment program discusses recent endovascular stroke trials, results, how to translate research into evidence-based practice as well as defines the patients who could benefit from endovascular treatments Available on demand at www.stroke.org/endovascular.
Venous Thromboembolic Disease has important challenges, especially in the ED where many patients admitted are at a high risk of venous thromboembolism. Learn how to improve patient outcomes through thrombotic risk assessment methods and hear recommendations on an appropriate prescribing for prophylaxis. Click this link for a course description, then log-in to the ACEP site to access this program - your SEMPA log-in will work. If you need your SEMPA log-in call 877.297.7594 ext. 5.
Support made possible through an educational grant from Bristol-Myers Squibb and Pfizer, Inc., Boehringer-Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo, Inc. and Janssen Scientific Affairs LLC.
Copyright © 2013
Report a website issue